Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Genpharmasec Limited

Market Cap 432M 4.54M 3.92M 3.62M 3.39M 6.34M 6.44M 42.7M 16.65M 210M 17.05M 16.69M 728M P/E Ratio 2024
-545x
P/E Ratio 2025 94.5x
Enterprise Value 422M 4.44M 3.84M 3.54M 3.31M 6.21M 6.3M 41.77M 16.29M 206M 16.68M 16.33M 712M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
55.34%
Yield 2024 *
-
Yield 2025 -
1 week+0.88%
Current month-4.20%
1 month-4.20%
3 months+10.68%
6 months-17.39%
Current year-12.98%
1 week 1.09
Extreme 1.09
1.2
1 month 1.09
Extreme 1.09
1.34
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 57 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.88%-48.18%-70.39% 6.64M
-1.64%-3.17%-35.38%-13.04% 154B
-0.16%-1.80%-9.37%-4.84% 103B
+0.07%+2.41%-4.53%+57.08% 54.8B
+3.00%+0.30%+55.27%+51.53% 55.22B
-0.75%-3.25%-16.18%-41.67% 40.3B
-1.40%+8.93% - - 30.96B
+0.16%+3.44%-9.03%-40.61% 29.08B
-0.46%+4.55%+46.20%-7.99% 23.23B
-2.85%-3.53%-16.97%-1.50% 20.25B
Average -0.24%+1.00%-4.24%-7.94% 51.04B
Weighted average by Cap. +0.04%-0.31%-7.88%+0.83%

Financials

2024 2025
Net sales 304M 3.2M 2.76M 2.55M 2.38M 4.47M 4.54M 30.06M 11.72M 148M 12.01M 11.75M 512M 337M 3.55M 3.06M 2.82M 2.64M 4.95M 5.03M 33.34M 13M 164M 13.31M 13.03M 568M
Net income -1.26M -13.22K -11.42K -10.53K -9.85K -18.46K -18.75K -124K -48.46K -612K -49.63K -48.58K -2.12M 12.31M 130K 112K 103K 96.5K 181K 184K 1.22M 475K 5.99M 486K 476K 20.75M
Net Debt -179M -1.88M -1.63M -1.5M -1.4M -2.63M -2.67M -17.69M -6.9M -87.06M -7.06M -6.91M -301M -9.4M -98.93K -85.44K -78.74K -73.7K -138K -140K -930K -362K -4.58M -371K -363K -15.85M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
12/06/26 1.140 0.00% 314,097
11/06/26 1.140 0.00% 143,833
10/06/26 1.140 +2.70% 380,398
09/06/26 1.110 0.00% 718,590
08/06/26 1.110 -1.77% 277,605
  1. Stock Market
  2. Stocks
  3. 531592 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!